✦ LIBER ✦

The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes (Review Article)

✍ Scribed by SOPHIA ZOUNGAS; PETER G KERR; MICHELLE LUI; HELENA J TEEDE

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dapagliflozin treatment in patients with

✍ L. Zhang; Y. Feng; J. List; S. Kasichayanula; M. Pfister 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Losartan and the United States costs of

✍ Alexander, Charles M.; Lyle, Paulette A.; Keane, William F.; Carides, George W.; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 78 KB

PSYCHOSOCIAL FACTORS IN PATIENTS WITH CH

✍ Samir S. Patel; Rolf A. Peterson; Paul L. Kimmel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Baseline predictors of end-stage renal d

✍ Shahinfar, Shahnaz; Zhongxin, Tanya Dickson; Keane, William F.; Brenner, Barry M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Improvement of glycaemic control by nate

✍ J.-M. González-Clemente; on behalf of the Spanish Nateglinide Study Group 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Influence of the CYP2D6 polymorphism and

✍ Hadi Molanaei; Juan Jesus Carrero; Olof Heimbürger; Louise Nordfors; Bengt Lindh 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 174 KB